AAAAAA
Results: 26-48/48
Authors:
Wierzbicki, AS
Hardman, TC
Cheung, J
Lambert-Hammill, M
Patel, S
Morrish, Z
Lumb, PJ
Lant, AF
Citation: As. Wierzbicki et al., Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporter, J HUM HYPER, 14(9), 2000, pp. 561-565
Authors:
Lloyd, G
McGing, E
Cooper, A
Patel, N
Lumb, PJ
Wierzbicki, AS
Jackson, G
Citation: G. Lloyd et al., A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women, J HUM HYPER, 14(2), 2000, pp. 99-104
Authors:
Mikhailidis, DP
Wierzbicki, AS
Citation: Dp. Mikhailidis et As. Wierzbicki, Attaining united states and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study), CURR MED R, 16(3), 2000, pp. 205-207
Authors:
Mikhailidis, DP
Wierzbicki, AS
Citation: Dp. Mikhailidis et As. Wierzbicki, HDL-cholesterol and the treatment of coronary heart disease: Contrasting effects of atorvastatin and simvastatin, CURR MED R, 16(2), 2000, pp. 139-146
Authors:
Reynolds, TM
Wierzbicki, AS
Citation: Tm. Reynolds et As. Wierzbicki, Classification of acute MI, EUR HEART J, 21(10), 2000, pp. 857-858
Authors:
Wierzbicki, AS
Lambert-Hammill, M
Lumb, PJ
Crook, MA
Citation: As. Wierzbicki et al., Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia, HYPERTENSIO, 36(5), 2000, pp. 808-812
Authors:
Reynolds, TM
Wierzbicki, AS
Citation: Tm. Reynolds et As. Wierzbicki, Effects of statins, LANCET, 356(9236), 2000, pp. 1195-1195
Authors:
Wierzbicki, AS
Swaminathan, R
Citation: As. Wierzbicki et R. Swaminathan, Coronary heart disease in Indian Asians, LANCET, 355(9216), 2000, pp. 1727-1728
Authors:
Wierzbicki, AS
Reynolds, TM
Crook, MA
Jackson, G
Citation: As. Wierzbicki et al., Are drugs interchangeable?, LANCET, 355(9200), 2000, pp. 317-317
Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London
Authors:
Alagratnam, D
Wierzbicki, AS
Swaminathan, R
Turner, C
Wickramasinghe, SN
Citation: D. Alagratnam et al., Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London, ATHEROSCLER, 149(1), 2000, pp. 221-222
Authors:
Wierzbicki, AS
Crook, MA
Nair, DR
Mikhailidis, DP
Winder, AF
Citation: As. Wierzbicki et al., More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia, ATHEROSCLER, 148(1), 2000, pp. 204-204
Authors:
Wierzbicki, AS
Crook, MA
Mikhailidis, DP
Winder, AF
Citation: As. Wierzbicki et al., Natural statins and stroke, CIRCULATION, 101(3), 2000, pp. E45-E45
Authors:
Wierzbicki, AS
Lumb, PJ
Chik, G
Crook, MA
Citation: As. Wierzbicki et al., High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia, AM J CARD, 86(5), 2000, pp. 547
Authors:
Wierzbicki, AS
Lumb, PJ
Semra, Y
Chik, G
Christ, ER
Crook, MA
Citation: As. Wierzbicki et al., Atorvastatin compared with simvastatin-based therapies in the management of severe familiar hyperlipidaemias, QJM-MON J A, 92(7), 1999, pp. 387-394
Authors:
Wierzbicki, AS
Lumb, PJ
Chik, G
Crook, MA
Citation: As. Wierzbicki et al., Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia, INT J CL PR, 53(8), 1999, pp. 609-611
Authors:
Wierzbicki, AS
Citation: As. Wierzbicki, The role of lipid lowering in transplantation, INT J CL PR, 53(1), 1999, pp. 54-59
Authors:
Wierzbicki, AS
Reynolds, TM
Citation: As. Wierzbicki et Tm. Reynolds, Cholesterol: How low is low enough? Doctors have been slow in getting evidence on lowering cholesterol into practice, BR MED J, 318(7182), 1999, pp. 539-539
Authors:
Hardman, TC
Dubrey, SW
Soni, S
Clifford, R
Chalkley, S
Wierzbicki, AS
Citation: Tc. Hardman et al., Urinary retinol-binding protein (RBP) excretion and erythrocyte sodium-lithium countertransport (SLC) activity in a cohort of healthy normotensive subjects, J HUM HYPER, 13(12), 1999, pp. 871-873
Authors:
Hardman, T
Clifford, RH
Wierzbicki, AS
Citation: T. Hardman et al., Erythrocyte Na+/Li+ countertransport and Na+/K+-2Cl(-) co-transport in essential hypertension, CLIN SCI, 97(3), 1999, pp. 339-340
Authors:
Wierzbicki, AS
Sankaralingam, A
Lumb, PJ
Hardman, TC
Sidey, MC
Gibberd, FB
Citation: As. Wierzbicki et al., Transport of phytanic acid on lipoproteins in Refsum disease, J INH MET D, 22(1), 1999, pp. 29-36
Authors:
Wierzbicki, AS
Crook, MA
Citation: As. Wierzbicki et Ma. Crook, Cholestatic liver dysfunction, LANCET, 354(9182), 1999, pp. 954-954
Authors:
Wierzbicki, AS
Crook, MA
Reynolds, TM
Jackson, G
Citation: As. Wierzbicki et al., Thrombotic vascular events after change of statin, LANCET, 353(9155), 1999, pp. 845-845
Authors:
Christ, ER
Cummings, MH
Albany, E
Umpleby, AM
Lumb, PJ
Wierzbicki, AS
Naoumova, RP
Boroujerdi, MA
Sonksen, PH
Russell-Jones, DL
Citation: Er. Christ et al., Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency:A stable isotope study, J CLIN END, 84(1), 1999, pp. 307-316